| Jennifer Ann Gehrke, APRN | |
|
1867 Airport Way Ste 140a, Fairbanks, AK 99701-4055 | |
| (907) 457-9355 | |
| Not Available |
| Full Name | Jennifer Ann Gehrke |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1867 Airport Way Ste 140a, Fairbanks, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124740808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 197762 (Alaska) | Primary |
| Entity Name | Polar Wind Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013933209 PECOS PAC ID: 8820082746 Enrollment ID: O20040413001417 |
News Archive
Post-traumatic stress disorder, or PTSD, continues to inflict a mental and physical toll on America's soldiers, leaving physical, emotional and spiritual scars long after these veterans have left their posts in Iraq and Afghanistan. Additionally, for female soldiers, sexual assault and rape can create similar, and many times more treatment-resistant, symptoms of PTSD, according to Dr. Kimberly Dennis.
Havas Health today announced the acquisition of Just:: Health Communications, a leading London agency known for its innovative work and for providing services to global clients in public relations, medical communications, public affairs and digital communications. Just:: was founded in 2006 by Jennie Talman and Emma Crozier.
Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe evaluating the safety and performance of the novel Esprit drug eluting bioresorbable vascular scaffold (BVS) for the treatment of blockages in the superficial femoral arteries (SFA) and iliac arteries that have resulted in claudication.
Pelvic examinations and cervical cancer screenings are no longer recommended for most females under age 21 during routine health visits, but a new study has found that millions of young women are unnecessarily undergoing the tests, which can lead to false-positive testing, over-treatment, anxiety and needless cost.
Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ann Gehrke, APRN Po Box 82807, Fairbanks, AK 99708-2807 Ph: (907) 378-4090 | Jennifer Ann Gehrke, APRN 1867 Airport Way Ste 140a, Fairbanks, AK 99701-4055 Ph: (907) 457-9355 |
News Archive
Post-traumatic stress disorder, or PTSD, continues to inflict a mental and physical toll on America's soldiers, leaving physical, emotional and spiritual scars long after these veterans have left their posts in Iraq and Afghanistan. Additionally, for female soldiers, sexual assault and rape can create similar, and many times more treatment-resistant, symptoms of PTSD, according to Dr. Kimberly Dennis.
Havas Health today announced the acquisition of Just:: Health Communications, a leading London agency known for its innovative work and for providing services to global clients in public relations, medical communications, public affairs and digital communications. Just:: was founded in 2006 by Jennie Talman and Emma Crozier.
Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe evaluating the safety and performance of the novel Esprit drug eluting bioresorbable vascular scaffold (BVS) for the treatment of blockages in the superficial femoral arteries (SFA) and iliac arteries that have resulted in claudication.
Pelvic examinations and cervical cancer screenings are no longer recommended for most females under age 21 during routine health visits, but a new study has found that millions of young women are unnecessarily undergoing the tests, which can lead to false-positive testing, over-treatment, anxiety and needless cost.
Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland.
› Verified 5 days ago
Mrs. Kelly Kay Binkowski, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1626 30th Ave, Fairbanks, AK 99701 Phone: 907-479-7701 | |
Ms. Krista Marie Johnson, CNM, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2054 30th Ave, Fairbanks, AK 99701 Phone: 907-456-3719 Fax: 907-456-1511 | |
Janice L Stables, MSN, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1867 Airport Way, Ste 110b, Fairbanks, AK 99701 Phone: 907-452-6330 Fax: 907-452-6335 | |
Anne Marie Lilley, RN, MSN, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1275 Sadler Way, #101, Fairbanks, AK 99701 Phone: 907-361-6370 Fax: 907-361-6372 | |
Susana Donofry, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 565 University Ave Ste 1, Fairbanks, AK 99709 Phone: 215-704-1238 | |
Alyce Lynne Weckwerth, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3100 S Cushman St, Fairbanks, AK 99701 Phone: 907-452-6251 Fax: 907-451-6251 | |
Mrs. Shannon Kay Rhoton, MSN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1919 Lathrop St, Suite 217, Fairbanks, AK 99701 Phone: 907-456-8191 Fax: 907-456-8192 |